Matches in Nanopublications for { ?s ?p "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246455.RAbHDPu3wsFA5pNNTL2IcPe7WkwXv5xJWrA3HLO0qUrGo130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246455.RAbHDPu3wsFA5pNNTL2IcPe7WkwXv5xJWrA3HLO0qUrGo130_provenance.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.
- NP1246460.RAZwBjogaq4TzYeGYm9iTiTcKLJgkK1f7BOIlgCcprrTo130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246460.RAZwBjogaq4TzYeGYm9iTiTcKLJgkK1f7BOIlgCcprrTo130_provenance.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.
- NP1246456.RAPNhLCDi-TTVGX7tecs-peyn7rzqH3y_-1h8po70vo3k130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246456.RAPNhLCDi-TTVGX7tecs-peyn7rzqH3y_-1h8po70vo3k130_provenance.
- NP1246459.RAH3oGPTWZJKOTV4MLVh-TLEOdCKBlP3qau6YMVKqz6K8130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246459.RAH3oGPTWZJKOTV4MLVh-TLEOdCKBlP3qau6YMVKqz6K8130_provenance.
- NP1246461.RAM4DUTMNzyvKv9W_8P0wDwthoZrI-B811XpxsHifvH7w130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246461.RAM4DUTMNzyvKv9W_8P0wDwthoZrI-B811XpxsHifvH7w130_provenance.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.